News summary

Cancer Drug Halts Fragile Brain Bleeds

Source: Neuroscience News • Published: 21 Oct 2026, 19:35

Summarized by Masters of Longevity from Neuroscience News.

Dabrafenib reduced brain vascular lesions and leakage in cell and mouse models of cerebral cavernous malformation.

Cancer Drug Halts Fragile Brain Bleeds
Key Takeaways
  • Dabrafenib reduced lesion size and number in mouse models.
  • The drug restored cell junctions and reduced vessel leakage.
  • Benefit in human patients remains unproven by these preclinical findings.
Read the full article at Neuroscience News ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.